Barchart.com's Chart of the Day - uniQure
Related Stocks
 QURE - Uniqure N.V.
SymLastChgPct
QURE36.25-0.08-0.22%

By Jim Van Meerten

TheChart of the Daybelongs touniQure(QURE). I found the gene therapy stock by using Barchart to sort today'sTop Stocks to Ownlist first for the highest Weighted Alpha then I used the Flipchart feature to review the charts for consistent price appreciation over the last 6 months. Since the Trend Spotter signaled a buy on 4/10 the stock gained 7.29%.

uniQure NV is involved in developing gene therapy for patients of genetic or acquired diseases. It offers Glybera for the treatment of lipoprotein lipase deficiency, an orphan metabolic disease. The company's product pipeline includes which are in clinical trials are additional adeno-associated virus consist of AMT-060, AMT-021, AMT-110 and AAV2/glial. uniQure NV is headquartered in Amsterdam, the Netherlands.

QURE

Barchart's Opinion trading systems are listed below. Please note that the Barchart Opinion indicators are updated live during the session every 10 minutes and can therefore change during the day as the market fluctuates. The indicator numbers shown below therefore may not match what you see live on theBarchart.comweb site when you read this report.

Barchart technical indicators:

  • 100% technical buy signals
  • 182.37+ Weighted Alpha
  • 417.62% gain in the last year
  • Trend Spotter buy signal
  • Above its 20, 50 and 100 day moving averages
  • 5 new highs and up 16.55% in the last month
  • Relative Strength Index 70.04%
  • Technical support level at 27.35
  • Recently traded at 29.03 with a 50 day moving average of 23.46

Fundamental factors:

  • Market Cap $919 million
  • 5 Wall Street analysts are following the stock but forecast decreasing revenue and earnings in the short term
  • Despite the short term forecast all 5 have given strong buy recommendations on the stock